Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Aug. 04, 2018	Jul. 29, 2017
Cash flows from operating activities:
Net income	$ 1,062,467	$ 379,609
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	169,651	138,368
Amortization of intangibles	428,222	255,955
Cost of goods sold for inventory acquired	0	316,678
Stock-based compensation expense	113,711	71,839
Deferred income taxes	(736,233)	(763,525)
Other non-cash activity	12,395	(18,613)
Changes in operating assets and liabilities	677,707	121,597
Total adjustments	665,453	122,299
Net cash provided by operating activities	1,727,920	501,908
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	0	(705,485)
Maturities of short-term available-for-sale investments	0	3,362,791
Sales of short-term available-for-sale investments	0	577,187
Additions to property, plant and equipment	(168,872)	(138,883)
Payments for acquisitions, net of cash acquired	(52,839)	(9,687,463)
Changes in other assets	(3,268)	(13,125)
Net cash used for investing activities	(224,979)	(6,604,978)
Cash flows from financing activities:
Proceeds from debt	743,778	11,156,164
Payments of deferred financing fees	0	(5,625)
Proceeds from derivative instruments	0	3,904
Debt repayments	(2,050,000)	(4,700,000)
Dividend payments to shareholders	(523,891)	(435,262)
Repurchase of common stock	(41,861)	(35,935)
Proceeds from employee stock plans	88,358	105,244
Contingent consideration payment	(2,272)	0
Changes in other financing activities	8,592	(7)
Net cash (used for) provided by financing activities	(1,777,296)	6,088,483
Effect of exchange rate changes on cash	(908)	2,024
Net decrease in cash and cash equivalents	(275,263)	(12,563)
Cash and cash equivalents at beginning of period	1,047,838	921,132
Cash and cash equivalents at end of period	$ 772,575	$ 908,569